| Title |
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
|
|---|---|
| Published in |
bioRxiv, September 2020
|
| DOI | 10.1101/2020.09.04.283853 |
| Authors |
Anne C. Moore, Emery G. Dora, Nadine Peinovich, Kiersten P. Tucker, Karen Lin, Mario Cortese, Sean N. Tucker |
X Demographics
The data shown below were collected from the profiles of 66 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 15 | 23% |
| Japan | 3 | 5% |
| United Kingdom | 3 | 5% |
| Canada | 3 | 5% |
| Ireland | 3 | 5% |
| Germany | 2 | 3% |
| Spain | 2 | 3% |
| India | 2 | 3% |
| Philippines | 1 | 2% |
| Other | 2 | 3% |
| Unknown | 30 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 59 | 89% |
| Scientists | 6 | 9% |
| Practitioners (doctors, other healthcare professionals) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 34 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 6 | 18% |
| Researcher | 6 | 18% |
| Other | 4 | 12% |
| Student > Master | 3 | 9% |
| Student > Ph. D. Student | 3 | 9% |
| Other | 5 | 15% |
| Unknown | 7 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 9 | 26% |
| Medicine and Dentistry | 6 | 18% |
| Immunology and Microbiology | 4 | 12% |
| Engineering | 2 | 6% |
| Environmental Science | 1 | 3% |
| Other | 4 | 12% |
| Unknown | 8 | 24% |